Insiders · Profile

Connaughton Bernadette

Director at HALOZYME THERAPEUTICS. Filing since 2 Sep 2025. CIK 0001662521

Company

Date

Role

Action

Shares

Amount

Of holding

HALO HALOZYME THERAPEUTICS, INC.

10 Aug 2026

Director

Sold on a plan

1,626

$167.15K

3.9%

HALO HALOZYME THERAPEUTICS, INC.

1 Jul 2026

Director

Sold on a plan

1,625

$124.65K

3.7%

HALO HALOZYME THERAPEUTICS, INC.

1 Jun 2026

Director

Sold on a plan

1,625

$107.59K

3.6%

HALO HALOZYME THERAPEUTICS, INC.

1 May 2026

Director

Sold on a plan

1,625

$103.16K

4.1%

HALO HALOZYME THERAPEUTICS, INC.

5 Jan 2026

Director

Sold on a plan

2,000

$140.50K

4.7%

HALO HALOZYME THERAPEUTICS, INC.

1 Dec 2025

Director

Sold on a plan

829

$59.36K

1.9%

HALO HALOZYME THERAPEUTICS, INC.

10 Nov 2025

Director

Sold on a plan

2,000

$136.96K

4.4%

HALO HALOZYME THERAPEUTICS, INC.

1 Oct 2025

Director

Sold on a plan

2,000

$150.48K

4.3%

HALO HALOZYME THERAPEUTICS, INC.

2 Sep 2025

Director

Sold on a plan

4,000

$294.74K

7.9%

9 decisions on file.